Are cardiovascular risk factors also associated with the incidence of atrial fibrillation?: A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants

Thrombosis and Haemostasis

Volumn 117, Issue 5, 2017, Pages 837-850

  Allan, Victoria ^a   Honarbakhsh, Shohreh ^b   Casas, Juan Pablo ^a   Wallace, Joshua ^a   Hunter, Ross ^b   Schilling, Richard ^b   Perel, Pablo ^c   Morley, Katherine ^d   Banerjee, Amitava ^a   Hemingway, Harry ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atrial fibrillation; Cardiovascular disease; Clinical guidelines; Primary prevention; Risk factors

Indexed keywords

ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; ELECTRONIC HEALTH RECORD; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; THYROID FUNCTION; ADULT; AGED; ANCESTRY GROUP; BLOOD; BLOOD PRESSURE; BODY HEIGHT; CARDIOVASCULAR DISEASE; COMORBIDITY; DYSLIPIDEMIA; FEMALE; INCIDENCE; LIFESTYLE; MALE; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

BIOLOGICAL MARKER; LIPID;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOMARKERS; BLOOD PRESSURE; BODY HEIGHT; CARDIOVASCULAR DISEASES; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 85019611220     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH16-11-0825     Document Type: Review

References (113)

1. Chugh SS, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129: 837-847.
2. Marini C, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36: 1115-1119.
3. Benjamin EJ, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952.
4. Blomstrom Lundqvist C, et al. What are the costs of atrial fibrillation? Europace 2011; 13 (Suppl 2): ii9-12.
5. Miyasaka Y, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
6. Krijthe BP, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013; 34: 2746-2751.
7. Savelieva I, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace 2011; 13: 308-328.
8. Moran PS, et al. Effectiveness of systematic screening for the detection of atrial fibrillation. Cochrane Database System Rev 2013; 4: Cd009586.
9. January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130: 2071-2104.
10. Kirchhof P, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart J 2016; Epub ahead of print.
11. Jones C, et al. The management of atrial fibrillation: summary of updated NICE guidance. Br Med J 2014; 348: g3655.
12. Perk J, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701.
13. Goldstein LB, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517-584.
14. Samokhvalov AV, et al. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prevent Rehabil 2010; 17: 706-712.
15. Kodama S, et al. Alcohol consumption and risk of atrial fibrillation: a metaanalysis. J Am Coll Cardiol 2011; 57: 427-436.
16. Larsson SC, et al. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014; 64: 281-289.
17. Wu N, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Internat J Cardiol 2013; 169: 62-72.
18. Huxley RR, et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011; 108: 56-62.
19. Wanahita N, et al. Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J 2008; 155: 310-315.
20. Ofman P, et al. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis. Circulation Arrhythm Electrophysiol 2013; 6: 252-256.
21. Kwok CS, et al. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Internat J Cardiol 2014; 177: 467-476.
22. Zimmerman D, et al. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 2012; 27: 3816-3822.
23. Ioannidis JP, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Internat J Epidemiol 2008; 37: 120-132.
24. Kuper H, et al. Evaluating the causal relevance of diverse risk markers: horizontal systematic review. Br Med J 2009; 339: b4265.
25. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 2009; 339: b2535.
26. Hemingway H, et al. Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med 2010; 7: e1000286.
27. Azarbal F, et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc 2014; 3: pii: e001127.
28. Perez MV, et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women’s Health Initiative Observational Study. Heart 2013; 99: 1173-1178.
29. Drca N, et al. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart 2014; 100: 1037-1042.
30. Watanabe H, et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009; 158: 629-636.
31. Watanabe H, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
32. Watanabe H, et al. Association between lipid profile and risk of atrial fibrillation. Circulation J 2011; 75: 2767-2774.
33. Drca N, et al. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart 2015; 101: 1627-1630.
34. Frost L, et al. Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study. Obesity 2014; 22: 1546-1552.
35. Frost L, et al. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 2005; 118: 489-495.
36. Frost L, et al. Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Occupat Environment Med 2005; 62: 49-53.
37. Fedorowski A, et al. Orthostatic hypotension and long-term incidence of atrial fibrillation: the Malmo Preventive Project. J Intern Med 2010; 268: 383-389.
38. Misialek JR, et al. Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study. J Am Heart Assoc 2014; 3: pii: e001159.
39. Huxley RR, et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study. Circulation Arrhyth Electrophysiol 2014; 7: 620-625.
40. Huxley RR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 1501-1508.
41. Lopez FL, et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circulation Arrhyth Electrophysiol 2012; 5: 155-162.
42. Alonso A, et al. Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study. Internat J Cardiol 2012; 155: 217-222.
43. Alonso A, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2009; 158: 111-117.
44. Marcus GM, et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 2010; 122: 2009-2015.
45. Alonso A, et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 2946-2953.
46. Chamberlain AM, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011; 107: 85-91.
47. Alonso A, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2013; 2: e000102.
48. Jensen PN, et al. Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study. J Am Geriatr Soc 2013; 61: 276-280.
49. Mozaffarian D, et al. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 2008; 118: 800-807.
50. Aviles RJ, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
51. Cappola AR, et al. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metabol 2015; 100: 1088-1096.
52. Deo R, et al. Impaired kidney function and atrial fibrillation in elderly subjects. J Cardiac Fail 2010; 16: 55-60.
53. Psaty BM, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
54. Smith JG, et al. Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010; 25: 95-102.
55. Smith JG, et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 2010; 56: 1712-1719.
56. Rosengren A, et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009; 30: 1113-1120.
57. Xu D, et al. Anemia and reduced kidney function as risk factors for new onset of atrial fibrillation (from the Ibaraki prefectural health study). Am J Cardiol 2015; 115: 328-333.
58. Schoen T, et al. Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. J Am Coll Cardiol 2012; 60: 1421-1428.
59. Everett BM, et al. Physical activity and the risk of incident atrial fibrillation in women. Circulation Cardiovasc Qual Outcom 2011; 4: 321-327.
60. Tedrow UB, et al. The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol 2010; 55: 2319-2327.
61. Mora S, et al. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circulation Arrhythm Electrophysiol 2014; 7: 612-619.
62. Sandhu RK, et al. Relation of renal function to risk for incident atrial fibrillation in women. Am J Cardiol 2012; 109: 538-542.
63. Conen D, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 2010; 31: 1730-1736.
64. Conen D, et al. Alcohol consumption and risk of incident atrial fibrillation in women. J Am Med Assoc 2008; 300: 2489-2496.
65. Conen D, et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009; 119: 2146-2152.
66. Thelle DS, et al. Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women. Heart 2013; 99: 1755-1760.
67. Nyrnes A, et al. Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromso Study. Eur J Prevent Cardiol 2013; 20: 729-736.
68. Nyrnes A, et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromso study. Gender Med 2012; 9: 536-547.e2.
69. Mitchell GF, et al. Pulse pressure and risk of new-onset atrial fibrillation. J Am Med Assoc 2007; 297: 709-715.
70. Schnabel RB, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739-745.
71. Alonso A, et al. Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study. J Am Heart Assoc 2014; 3: e001211.
72. Sawin CT, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-1252.
73. Schnabel RB, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 2009; 104: 92-96.
74. Adamsson Eryd S, et al. Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study. Eur J Epidemiol 2011; 26: 449-455.
75. Sinner MF, et al. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of communitybased cohort studies. Europace 2014; 16: 1426-1433.
76. Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med 2010; 170: 1909-1917.
77. Chaker L, et al. Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study. J Clin Endocrinol Metabol 2015; 100: 3718-3724.
78. Heeringa J, et al. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J 2008; 156: 1163-1169.
79. Friberg J, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003; 14: 666-672.
80. Mukamal KJ, et al. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol 2006; 98: 75-81.
81. Aronis KN, et al. Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults. Am Heart J 2015; 170: 498-505.e2.
82. Collet TH, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012; 172: 799-809.
83. Knuiman M, et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol 2014; 29: 181-190.
84. Roetker NS, et al. Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2014; 114: 587-592.
85. Rodriguez CJ, et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol 2015; 25: 71-76, 6.e1.
86. Bapat A, et al. Relation of Physical Activity and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2015; 116: 883-888.
87. O’Neal WT, et al. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Hyperten 2015; 9: 191-196.
88. Sano F, et al. Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS). Circulation J 2014; 78: 955-961.
89. Nystrom PK, et al. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PloS one 2015; 10: e0127111.
90. Grundvold I, et al. Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men. Am J Cardiol 2012; 110: 425-432.
91. Kokubo Y, et al. Interaction of Blood Pressure and Body Mass Index With Risk of Incident Atrial Fibrillation in a Japanese Urban Cohort: The Suita Study. Am J Hyperten 2015; 28: 1355-1361.
92. Dewland TA, et al. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 2013; 128: 2470-2477.
93. Lindhardsen J, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. Br Med J 2012; 344: e1257.
94. Ahlehoff O, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J 2012; 33: 2054-2064.
95. Pallisgaard JL, et al. Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. Eur J Prevent Cardiol 2016; 23: 621-627.
96. Selmer C, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. Br Med J 2012; 345: e7895.
97. Emilsson L, et al. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 2011; 32: 2430-2437.
98. Chiang CH, et al. Herpes simplex virus infection and risk of atrial fibrillation: a nationwide study. Internat J Cardiol 2013; 164: 201-204.
99. Gorenek B, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace 2016; Epub ahead of print.
100. Schneider MP, et al. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol 2010; 55: 2299-2307.
101. Emdin CA, et al. Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials. Europace 2015; 17: 701-710.
102. Rahimi K, et al. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. Br Med J 2011; 342: d1250.
103. Rapsomaniki E, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383: 1899-1911.
104. Lokaj P, et al. Pulse Pressure in Clinical Practice. Eur J Cardiovasc Med 2012; 2: Abstract.
105. National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. Available at: https://www.nice.org.uk/guid ance/cg127. Accessed March 1, 2016.
106. Danesh J, et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007; 22: 839-869.
107. Denaxas SC, et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Internat J Epidemiol 2012; 41: 1625-1638.
108. Montori VM, et al. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. Br Med J 2005; 330: 68.
109. Kwon Y, et al. An assessment of the efficacy of searching in biomedical databases beyond MEDLINE in identifying studies for a systematic review on ward closures as an infection control intervention to control outbreaks. System Rev 2014; 3: 135.
110. Stevinson C, Lawlor DA. Searching multiple databases for systematic reviews: added value or diminishing returns? Complement Therap Med 2004; 12: 228-232.
111. Lemeshow AR, et al. Searching one or two databases was insufficient for metaanalysis of observational studies. J Clin Epidemiol 2005; 58: 867-873.
112. Horton R. The less acceptable face of bias. Lancet 2000; 356: 959-960.
113. Nelson CP, Hamby SE, Saleheen D, et al. Genetically determined height and coronary artery disease. N Engl J Med 2015; 372: 1608-1618.